GNPX
Price
$2.21
Change
-$0.19 (-7.92%)
Updated
Feb 4, 02:44 PM (EDT)
Capitalization
5.45M
Intraday BUY SELL Signals
HOWL
Price
$0.61
Change
-$0.05 (-7.58%)
Updated
Feb 4, 02:47 PM (EDT)
Capitalization
32.14M
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GNPX vs HOWL

Header iconGNPX vs HOWL Comparison
Open Charts GNPX vs HOWLBanner chart's image
Genprex
Price$2.21
Change-$0.19 (-7.92%)
Volume$330
Capitalization5.45M
Werewolf Therapeutics
Price$0.61
Change-$0.05 (-7.58%)
Volume$501
Capitalization32.14M
GNPX vs HOWL Comparison Chart in %
GNPX
Daily Signal:
Gain/Loss:
HOWL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GNPX vs. HOWL commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and HOWL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (GNPX: $2.40 vs. HOWL: $0.66)
Brand notoriety: GNPX and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 79% vs. HOWL: 39%
Market capitalization -- GNPX: $5.45M vs. HOWL: $32.14M
GNPX [@Biotechnology] is valued at $5.45M. HOWL’s [@Biotechnology] market capitalization is $32.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, both GNPX and HOWL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 3 TA indicator(s) are bullish while HOWL’s TA Score has 5 bullish TA indicator(s).

  • GNPX’s TA Score: 3 bullish, 6 bearish.
  • HOWL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than GNPX.

Price Growth

GNPX (@Biotechnology) experienced а +1.69% price change this week, while HOWL (@Biotechnology) price change was -1.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

HOWL is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOWL($32.1M) has a higher market cap than GNPX($5.45M). GNPX YTD gains are higher at: 37.143 vs. HOWL (4.515). GNPX has higher annual earnings (EBITDA): -16.38M vs. HOWL (-65.99M). HOWL has more cash in the bank: 65.7M vs. GNPX (1.1M). GNPX has less debt than HOWL: GNPX (279K) vs HOWL (37.3M). GNPX (0) and HOWL (0) have equivalent revenues.
GNPXHOWLGNPX / HOWL
Capitalization5.45M32.1M17%
EBITDA-16.38M-65.99M25%
Gain YTD37.1434.515823%
P/E Ratio0.09N/A-
Revenue00-
Total Cash1.1M65.7M2%
Total Debt279K37.3M1%
FUNDAMENTALS RATINGS
GNPX: Fundamental Ratings
GNPX
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
21

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNPXHOWL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signal:
Gain/Loss:
HOWL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LI17.020.48
+2.90%
Li Auto
ABM45.65-0.72
-1.55%
ABM Industries
CGTX1.12-0.02
-1.75%
Cognition Therapeutics
AVR5.92-0.23
-3.74%
Anteris Technologies Global Corp
BGMS1.04-0.09
-7.96%
Bio Green Med Solution Inc

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with NERV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then NERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-3.61%
NERV - GNPX
64%
Loosely correlated
+5.34%
TOVX - GNPX
50%
Loosely correlated
+3.37%
OMER - GNPX
48%
Loosely correlated
+0.85%
REVB - GNPX
48%
Loosely correlated
-11.17%
APVO - GNPX
33%
Poorly correlated
-10.34%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GANX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-2.42%
GANX - HOWL
48%
Loosely correlated
+1.69%
PYXS - HOWL
41%
Loosely correlated
-2.61%
GNPX - HOWL
40%
Loosely correlated
-3.61%
RXRX - HOWL
39%
Loosely correlated
-1.91%
BCRX - HOWL
38%
Loosely correlated
+1.06%
More